Related Experiment Videos
Accessing three-dimensional chemical information in antibody molecules
1Research Products and Services, ImmunoPharmaceutics, Inc., San Diego, CA 92127.
American Biotechnology Laboratory
|April 1, 1993
Summary
Monoclonal antibody structural insights from X-ray crystallography and computer modeling reveal new ways to modify antibodies. This antibody technology advances disease treatment, diagnosis, and drug design.
Area of Science:
- Biochemistry and Structural Biology
- Immunology
- Drug Discovery
Background:
- Monoclonal antibodies (mAbs) are crucial in modern medicine.
- Understanding mAb structure is key to optimizing their therapeutic potential.
Purpose of the Study:
- To explore how structural analysis of monoclonal antibodies can inform therapeutic development.
- To highlight the role of X-ray crystallography and computational modeling in antibody engineering.
Main Methods:
- X-ray crystallographic analysis of monoclonal antibodies.
- Computer modeling techniques focused on complementarity-determining region (CDR) loops.
Main Results:
- Detailed structural information was successfully obtained from monoclonal antibodies.
- Computational modeling provided insights into CDR loop conformations and flexibility.
Conclusions:
- Structural insights from X-ray crystallography and modeling offer novel approaches for antibody modification.
- These advancements facilitate improved antibody-based disease treatment, diagnosis, and drug design.